Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Bradykinin B2 Receptor Antagonists/therapeutic use , Bradykinin/analogs & derivatives , COVID-19 Drug Treatment , Bradykinin/therapeutic use , COVID-19/diagnosis , COVID-19/physiopathology , Humans , Lung/drug effects , Lung/physiopathology , Male , Middle Aged , SARS-CoV-2 , Treatment OutcomeABSTRACT
Gitelman's syndrome is a rare autosomal-recessive tubular disorder characterized by hypomagnesemia and hypocalciuria associated to hypokalemia. The clinical spectrum is wide and usually characterized by chronic fatigue, cramps, muscle weakness and paresthesiae. We describe a case of a 43 year-old male patient with early onset of knee arthritis and no other symptoms. Ultrasound revealed diffuse and confluent hyperechoic deposits in cartilage, fibrocartilage of the menisci and synovium and calcium pyrophosphate crystals were observed in the synovial fluid of the knee. The concomitant presence of hypomagnesemia, hypocalciuria and hypokalemia made clear the diagnosis of Gitelman's syndrome associated with chondrocalcinosis.
Subject(s)
Chondrocalcinosis/diagnosis , Chondrocalcinosis/etiology , Gitelman Syndrome/complications , Gitelman Syndrome/diagnosis , Ultrasonography , Adult , Biomarkers/blood , Calcium/blood , Calcium/urine , Chondrocalcinosis/blood , Diagnosis, Differential , Early Diagnosis , Gitelman Syndrome/blood , Gitelman Syndrome/genetics , Humans , Hypokalemia/blood , Magnesium/blood , Male , Mutation , Risk Assessment , Severity of Illness Index , Solute Carrier Family 12, Member 3/bloodABSTRACT
Since the introduction of combined antiretroviral therapy, human immunodeficiency virus (HIV) infection is no longer a contraindication for solid organ transplantation. In HIV/hepatitis C virus (HCV)-coinfected patients undergoing liver transplantation, HCV-related cirrhosis, drug-drug interactions, and calcineurin inhibitors-related toxicity affect clinical outcomes. Therapeutic drug monitoring can be useful to assess antiretroviral over- or underexposure in this cohort. We report the clinical characteristics along with antiretroviral trough levels of maraviroc, darunavir, and etravirine in 3 HIV/HCV-coinfected liver transplant recipients who developed post-transplant liver cirrhosis.
Subject(s)
Anti-Retroviral Agents/blood , HIV Infections/drug therapy , Hepatitis C/drug therapy , Liver Cirrhosis/drug therapy , Liver Transplantation/adverse effects , Anti-Retroviral Agents/pharmacokinetics , Coinfection , Cyclohexanes/blood , Cyclohexanes/pharmacokinetics , Darunavir/blood , Darunavir/pharmacokinetics , Drug Monitoring , Female , HIV Infections/complications , HIV Infections/surgery , Hepatitis C/complications , Hepatitis C/surgery , Humans , Liver Cirrhosis/surgery , Male , Maraviroc , Middle Aged , Nitriles , Pyridazines/blood , Pyridazines/pharmacokinetics , Pyrimidines , Triazoles/blood , Triazoles/pharmacokineticsABSTRACT
The reaction of CH(3)Co(DH)(2)H(2)O with 4-pyridinyl boronic acid in methanol or water affords the dinuclear complexes [MeCo(DH)(DB(OR)(4-Py))](2), with R = Me (2) or H (3), respectively, through reaction of boron with the oxime oxygens of the alkylcobaloxime and coordination of the pyridinyl N to cobalt. The reaction is strongly pH dependent, and the formation of the complexes requires a neutral medium. The complexes have been fully characterized by (1)H and (13)C NMR spectroscopy, ESI-MS spectrometry, and elemental analysis. The X-ray structure shows that in 2, the pyridinyl groups are facing each other and nearly perpendicular both to the plane of the Co B Co1 B1 atoms and to the mean equatorial plane, so that the complex may be considered a molecular box. A dimeric arrangement has already been found in the related [MeCo(DH)(DB(OMe)(3-Py))](2) (1) complex, which forms a distorted molecular rectangle [Dreos, R.; Nardin, G.; Randaccio, L.; Tauzher, G.; Vuano, S. Inorg. Chem. 1997, 36, 2463]. The dimerization is possible in both cases, as the conformational freedom of the B bridge compensates for the different position (3- or 4-) of the pyridinyl N donor.
ABSTRACT
Treatment of R = -CH(2)X (X = halogen) derivatives of the type [RCo(III)(LNH-py)(HLNH-py)](+), where HLNH-py = 2-(2-pyridyl-ethyl)amino-3-butanone oxime and LNH-py its conjugated base with diluted NaOH, afforded a new complex containing a three-membered ring by a pathway involving the intramolecular nucleophilic addition of an equatorial nitrogen donor to the axial carbon. The X-ray analysis reveals a highly distorted structure. The C-Co-N angle is acute (42.8 degrees ) with the distortion of the coordination sphere concentrated in the Co-C axial and Co-N bonds, which move away from the pseudo-octahedral positions in the CH(2)X parent complex to form the C-N bond of the metallocycle. Kinetic studies of the formation of this novel complex starting from [(XCH(2)Co(III)(LNH-py)(HLNH-py)](+) (X = Cl,Br,I) showed that the metallocycle formation rates increase in the order Cl < Br < I. Kinetic data are consistent with a mechanism involving an intermediate species resulting from the deprotonation of an amine equatorial nitrogen in a rapid preequilibrium, followed by the slow step of the ring closure.